JS
About
Jurek is Executive in Residence at the London Business School and non-Executive Director of AIM listed Intercede Group Plc. Jurek has over 30 years’ experience in the pharmaceutical, medical devices, in vitro diagnostics and biotechnology industries.This includes roles as the Chief Executive of SRS Technology Group Plc, Cantab Pharmaceuticals Plc and Proteus International Plc. Jurek has led IPO and secondary fund raising and negotiated M&A, distribution, license and developments agreements with large corporates including Tunstall, the UK largest Telecare provider.
Position in the VCSift Database
- • 3 investors at London Business School are tracked.
- • 17 investors hold the Executive in Residence role in VCSift. Jurek Sikorski is one of them.
- • 43 investors are based in Reading, Reading, United Kingdom.
Data sourced from 410,343 investor profiles. Updated July 2026.
Investment Focus
- Location
- Reading, UK
Contact Information
linkedin.com/in/••••••••
Find more investors like Jurek
Search Investors